Zenith Capital Corporation

Equities

ZENI.P

CA98936P1071

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 11:00:00 2024-04-16 am EDT			5-day change	1st Jan Change
0.105 ^CAD	0.00%		0.00%	0.00%

Mar. 28	Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
2023	Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	CI

Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023

March 28, 2023 at 02:08 pm EDT

Zenith Capital Corporation reported earnings results for the second quarter and six months ended January 31, 2023. For the second quarter, the company reported net loss was CAD 0.047328 million compared to CAD 0.047122 million a year ago.
For the six months, net loss was CAD 0.063938 million compared to CAD 0.103345 million a year ago.

Latest news about Zenith Capital Corporation

Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Mar. 27	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	Nov. 27	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-14	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-28	CI
Grand Samsara Consulting LLC and CBGB Ventures Corp. signed a binding letter agreement to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	23-03-19	CI
Zenith Capital Corporation announced that it expects to receive CAD 1 million in funding from Grand Samsara Consulting LLC	23-03-07	CI
Zenith Capital Corporation announced that it has received CAD 0.2 million in funding	23-02-22	CI
Zenith Capital Corporation announced that it expects to receive CAD 0.2 million in funding	23-02-14	CI
Venda Robotix Ltd cancelled the acquisition of Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction..	23-01-22	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-08	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	22-11-16	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-21	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	22-03-28	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	21-11-29	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	21-11-08	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	21-11-07	CI
Venda Robotix Ltd entered into a binding letter of intent to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	21-08-17	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	21-06-02	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021	21-03-05	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2020	20-10-15	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	20-10-14	CI
Zenith Capital Corporation announced that it has received $2.000001 million in funding	20-06-15	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2020	20-06-08	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2020	20-03-10	CI
Zenith Capital Corporation has completed an IPO in the amount of CAD 0.2 million.	20-03-06	CI

Chart Zenith Capital Corporation

Duration

Period

More charts

Company Profile

Zenith Capital Corporation is a Canada-based capital pool company. The principal activity of the Company is the identification and evaluation of assets or a business and, once identified or evaluated, to negotiate an acquisition of, or participation in, a business subject to receipt of shareholders approval, if required, and acceptance by regulatory authorities (the Qualifying Transaction). The Company has not identified a business or asset that warrants acquisition or participation.

Sector

Biotechnology & Medical Research

Calendar

2024-06-10 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ZENITH CAPITAL CORPORATION	0.00%	323K
IQVIA HOLDINGS INC.	+2.42%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.04%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.04%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-22.60%	18.12B
MEDPACE HOLDINGS, INC.	+30.39%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.06%	11.76B
UNITED THERAPEUTICS CORPORATION	+9.06%	11B

Other Biotechnology & Medical Research